Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Ariel M. Modrykamien"'
Autor:
Sumeet K. Asrani, Puneeta Tandon, James F. Trotter, Jacqueline G. O'Leary, Patrick S. Kamath, Michael D. Leise, Rakhi Maiwall, Jasmohan S. Bajaj, Gerald O. Ogola, Andrew L. Masica, Florence Wong, Ariel M. Modrykamien, Elliot B. Tapper, K. Rajender Reddy, Ranjeeta Bahirwani, Maria Kouznetsova, Leroy R. Thacker, Naveed Sarmast
Publikováno v:
Hepatology. 72:1747-1757
BACKGROUND AND AIMS Compared to other chronic diseases, patients with chronic liver disease (CLD) have significantly higher inpatient mortality; accurate models to predict inpatient mortality are lacking. Serum lactate (LA) may be elevated in patient
Publikováno v:
Proc (Bayl Univ Med Cent)
The acute respiratory distress syndrome (ARDS) is a major cause of acute respiratory failure. Its development leads to high rates of mortality, as well as short- and long-term complications, such as physical and cognitive impairment. Therefore, early
Publikováno v:
Baylor University Medical Center Proceedings
Proc (Bayl Univ Med Cent)
Proc (Bayl Univ Med Cent)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or novel coronavirus disease 2019 (COVID-19) emerged from China in December 2019 and progressed to become a global pandemic. Our understanding of its pathophysiology and potential managemen
Autor:
Yahya Daoud, Ariel M. Modrykamien
Publikováno v:
Baylor University Medical Center Proceedings. 31:1-5
Optimal mechanical ventilation management in patients with the acute respiratory distress syndrome (ARDS) involves the use of low tidal volumes and limited plateau pressure. Refractory hypoxemia may not respond to this strategy, requiring other inter
Publikováno v:
Respiratory Care. 62:947-952
BACKGROUND: Administration of cisatracurium in severe ARDS decreases in-hospital mortality. Whether clinical outcomes are cisatracurium-specific or related with all neuromuscular blockers is unknown. This study aimed to compare outcomes in severe ARD
Autor:
Ariel M. Modrykamien
Publikováno v:
American Journal of Disaster Medicine. 15:141-142
Publikováno v:
Baylor University Medical Center Proceedings. 31:177-179
Acute respiratory distress syndrome is the result of an acute inflammatory response of the lungs, causing severe hypoxemia. A variety of therapeutic modalities have been extensively studied, with only a few demonstrating improvement in survival. Spec
Publikováno v:
Proceedings (Baylor University. Medical Center). 33(1)
Epoprostenol, a pulmonary vasodilator, is used to reduce pulmonary artery pressure. Its inhaled administration results in ventilation and perfusion matching with oxygenation improvement. Epoprostenol is used as treatment for various conditions, parti
Autor:
Ariel M. Modrykamien
Publikováno v:
Proceedings (Baylor University. Medical Center). 32(4)
Critically ill patients admitted to the intensive care unit (ICU) frequently require ventilatory support. To provide this life-saving therapy, oral intubation or tracheostomy placements are needed. Consequently, verbal ability to communicate is lost.
Publikováno v:
Critical Care Medicine. 49:634-634